MedPath

Lupimet

Brand Name: Lupimet

Generic Name: Glimepiride + Metformin Hydrochloride

Active
Registration Number

DRP-9979

Dosage Form

Sustained- Release Tablet

Issuance Date

January 31, 2024

Expiry Date

February 4, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2mg/500mg
PackagingAluminum/PVC/PVDC Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Blood Glucose Lowering Drugs excl. Insulins
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

GlimepirideActive
Monograph: Glimepiride
Metformin HydrochlorideActive
Monograph: Metformin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform